Medicine & Life Sciences
Neoplasms
100%
ErbB Receptors
58%
Zoledronic Acid
56%
Histone Deacetylase Inhibitors
55%
Apoptosis
52%
Vorinostat
47%
raltitrexed
46%
8-chloro-cyclic adenosine monophosphate
45%
Colorectal Neoplasms
45%
Rectal Neoplasms
44%
Growth
44%
Interferons
41%
Fluorouracil
38%
Prostatic Neoplasms
38%
Therapeutics
37%
Valproic Acid
36%
Breast Neoplasms
34%
Squamous Cell Carcinoma of Head and Neck
32%
Proteins
31%
Proteomics
30%
Oxaliplatin
29%
Epidermal Growth Factor
28%
tipifarnib
27%
Bevacizumab
26%
Cell Line
26%
Histone Deacetylases
25%
Pharmaceutical Preparations
25%
Cyclic AMP-Dependent Protein Kinases
24%
Gefitinib
24%
Drug Therapy
23%
KB Cells
21%
Neoplasm Metastasis
21%
Calreticulin
21%
Radiotherapy
20%
Capecitabine
19%
Metabolomics
19%
Phenotype
19%
Neoplastic Stem Cells
19%
Cisplatin
18%
Chemoradiotherapy
18%
Survival
18%
Triple Negative Breast Neoplasms
18%
Protein-Tyrosine Kinases
18%
Antineoplastic Agents
18%
Leucovorin
17%
transglutaminase 2
17%
Head and Neck Neoplasms
17%
Non-Small Cell Lung Carcinoma
16%
Down-Regulation
16%
In Vitro Techniques
16%
Chemical Compounds
Protein
33%
Vorinostat
26%
Antitumor
24%
Drug
20%
Resistance
19%
Hypusine
18%
Histone
18%
Tyrosine Kinase Inhibitor
15%
Gefitinib
14%
Antiproliferative
14%
Growth Factor
13%
Biological Marker
13%
Protein Synthesis
11%
Rectal
11%
Antiapoptotic
10%
Antiangiogenic
10%
Pharmacological Metabolism
9%
Zoledronic Acid
9%
Glycosphingolipid
9%
Melatonin
9%
Growth Inhibition
9%
Thyroid
9%
Metabolite
9%
Modification
9%
Signal Transduction
8%
Peptide
8%
Antineoplastic Agent
8%
Depolarization
8%
Spreading
7%
Antiinflammatory
7%
Polyphenol
7%
Reactive Oxygen Metabolite
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Mutation
7%
MicroRNA
6%
Metabolic
6%
Urotensin II
6%
Marker
6%
Peroxisome Proliferator Activated Receptor Agonist
6%
Troglitazone
6%
Mevalonate
6%
Niclosamide
6%
Prenylation
6%
Angiogenesis Inhibitor
6%
Cell Viability
6%
Transferase Inhibitor
6%
Cisplatin
6%
Temozolomide
6%
Cell Death
6%
Cetirizine
6%